A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer
2011 ◽
Vol 30
(5)
◽
pp. 2026-2031
◽
Keyword(s):
Phase Ii
◽
2013 ◽
Vol 72
(5)
◽
pp. 1097-1102
◽
2007 ◽
Vol 96
(3)
◽
pp. 439-444
◽